Seoul National University Bundang Hospital (SNUBH)
Cirrhosis treatment cost in South Korea typically depends on the clinical stage, with a consultation with a hepatologist running from AUD $143 to AUD $286. Surgical options like a liver transplant range from AUD $183,020 to AUD $223,342 depending on the complexity and clinic choice. Patients generally save around 30–50% compared to private healthcare costs in Australia and the United States. Seoul and Incheon are the primary medical hubs for advanced liver care.
Typical Cirrhosis Treatment Costs in South Korea
Bookimed Expert Insight: Patients with advanced liver failure should target high-volume transplant centres for better safety. Asan Medical Center reports a 90% organ transplant success rate and handles massive patient volumes. For those exploring alternative therapies, Re:Youth clinic specialises in arterial stem cell delivery. They use a unique delivery system designed to ensure all cells reach the targeted organ directly.
| Republic of Korea | Thailand | Turkey | |
| Liver transplant | from AUD $183,020 | from AUD $114,388 | from AUD $64,343 |
| Stem cell treatment for liver cirrhosis | - | from AUD $21,448 | from AUD $17,158 |
No hidden fees – just official clinic prices. Pay at the clinic for Cirrhosis treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Cirrhosis treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Cirrhosis treatment journey.
Dr. Cheon Won Seok is the Director of the Department of Gastroenterology at Naeun Hospital. His expertise includes gastrointestinal diseases; upper gastrointestinal endoscopy and colonoscopy; polypectomy; ESD (Endoscopic Submucosal Dissection); small-bowel capsule endoscopy; digestive disorders; gastric and esophageal cancer; Helicobacter pylori infection; liver diseases; and inflammatory bowel disease, including Crohn’s disease and ulcerative colitis.
He graduated from Kyung Hee University College of Medicine. He completed his internship at Kyung Hee Medical Center and his internal medicine residency at Hallym University Sacred Heart Hospital. He later served as a Clinical Instructor in Gastroenterology at Chung-Ang University Hospital. He is a full member of the Korean Association of Internal Medicine and a life member of the Korean Society of Gastrointestinal Endoscopy. He is also a board-certified subspecialist in gastrointestinal endoscopy and serves as a medical advisor to KBS, MBC, SBS, JTBC, and MBN.
Living donor liver transplantation in South Korea achieves survival rates of 89.9% to 98% after one year. Leading JCI-accredited Seoul centres report 5-year survival rates exceeding 80%. These outcomes often surpass Western standards through surgical techniques and specialised donor-matching protocols for cirrhosis patients.
Bookimed Expert Insight: South Korea leads the world in clinical experience for living donor transplants. Asan Medical Center performs nearly half of the country's heart transplants. It also maintains high-volume liver programmes. This concentration of cases allows surgeons to perfect right-lobe graft techniques. These methods significantly improve safety for the living donor.
Patient Consensus: Patients often highlight quick donor evaluations and shorter waiting times than the Australian healthcare system. Many note the high level of technical skill and intensive follow-up care provided during their stay in Seoul.
Asan Medical Center and Severance Hospital lead Seoul's medical care system. They are globally recognised for liver cirrhosis treatment. These centres hold JCI and KOIHA accreditations. They offer specialised services including liver transplantation and arterial stem cell therapy.
Bookimed Expert Insight: South Korea's liver care landscape is defined by high specialisation and volume. Asan Medical Center treats over 182,000 patients annually. It serves as a major hub for international medical tourists. For patients seeking non-surgical options, the RE:YOUTH clinic focuses on regenerative medicine. They limit intake to two patients daily for intensive medical attention.
South Korean hospitals provide non-surgical cirrhosis management through antiviral therapies, lifestyle medicine, and regenerative stem cell treatments. Specialists like Dr Cheon Won Seok at Na-Eun Hospital use endoscopy to manage complications. Major Seoul centres also offer TIPS procedures to reduce portal vein pressure without open surgery.
Bookimed Expert Insight: Many major hospitals like Asan Medical Center focus on high-volume organ transplants. However, smaller specialised clinics like RE:YOUTH offer a different approach. They limit intake to two patients daily. This provides focused attention for complex regenerative therapies often unavailable in standard surgical units.
Patient Consensus: Patients note that alcohol abstinence and salt reduction are vital for managing ascites. They also emphasise the need for long-term hepatologist review in Korea to monitor progression and screen for liver cancer.
South Korea hosts specialists for liver disease management, particularly in hepatology and liver transplantation. Major centres like Asan Medical Center and Seoul National University Hospital offer specialised care. These facilities hold JCI or GHA accreditations. They maintain high success rates for complex conditions such as cirrhosis.
Bookimed Expert Insight: Many Australian patients look for hepatology care. Korean data shows a unique focus on high-volume digital integration. Clinics like Seoul National University Bundang Hospital use the BESTcare digital system to track patient data. This reduces medical errors and improves safety for international patients managing complex conditions like cirrhosis.